Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
3.050
0.00 (0.00%)
At close: Mar 28, 2024, 4:00 PM
3.040
-0.010 (-0.33%)
After-hours: Mar 28, 2024, 5:02 PM EDT

Ovid Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-52.34-54.17122.83-81.04-60.46-51.98-64.81-22.41-13.16
Depreciation & Amortization
1.61.380.240.310.260.140.080.060.01
Share-Based Compensation
7.296.565.057.535.217.066.43.641.46
Other Operating Activities
-2.32-9-9.5121.623.91-0.7826.860.916.21
Operating Cash Flow
-45.78-55.23118.61-51.58-51.09-45.56-31.47-17.8-5.49
Capital Expenditures
-0.04-1.22-0.18-0.13-0.06-0.03-0.04-0.03-0.03
Change in Investments
-2.44-86.46-1.6335.04-29.8-5.01000
Other Investing Activities
-0.1-0.19-0.01-0.26-0.19-0.32-0.01-0.16-0.02
Investing Cash Flow
-2.58-87.88-1.8234.65-30.04-5.36-0.05-0.19-0.06
Share Issuance / Repurchase
0.540.180.947.0786.540.2969.7800
Debt Issued / Paid
3000000000
Other Financing Activities
-------3.07-0.0170.64
Financing Cash Flow
30.540.180.947.0786.540.2966.7-0.0170.64
Net Cash Flow
-17.83-142.93117.6930.145.41-50.6435.19-1865.1
Free Cash Flow
-45.82-56.45118.43-51.71-51.15-45.59-31.51-17.83-5.52
Free Cash Flow Margin
-11698.19%-3756.55%56.83%-409.85%-----
Free Cash Flow Per Share
-0.65-0.801.75-0.89-1.30-1.85-1.63-1.81-0.57
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).